Surge in Mpox Cases Sparks UKHSA Urgency for Vaccination Amid European Outbreak

A surge in mpox cases across Europe, disconnected from known transmission areas, has prompted the UKHSA to push for vaccinations to combat the spread of the virus.

• The UK Health Security Agency (UKHSA) has reported a concerning increase in mpox cases in Europe, with infections appearing in areas with no direct ties to Africa or previous outbreaks.
• Health officials emphasize the importance of the vaccine for eligible individuals, as the global mpox outbreak continues to pose a threat, especially after its resurgence in 2022.
• Bavarian Nordics vaccine is currently being utilized in vaccination campaigns, particularly in response to case spikes in regions such as Uganda and Europe.